PMID: 1206575Nov 1, 1975Paper

Loss of alpha-bungarotoxin from junctional and extrajunctional acetylcholine receptors in rat diaphragm muscle in vivo and in organ culture

The Journal of Physiology
D K Berg, Z Hall

Abstract

Acetylcholine (ACh) receptors in rat diaphragm muscle were blocked by intrathoracic injection of alpha-bungarotoxin (alpha-BuTx) or [125I]alpha-bungarotoxin ([125I]alpha-BuTx). The stability in vivo of the toxin-receptor complex formed by receptors in normal muscles and receptors in extrajunctional regions of denervated muscles was compared. Toxin was lost from junctional regions of normal muscles with a half-time of approximately 6 days. The loss of toxin was accompanied by a corresponding increase in the number of free toxin-binding sites. In contrast, 65% of the toxin bound to extrajunctional regions of denervated muscle was lost in 24 hr. 2. In a second series of experiments, animals were injected with [125I]alpha-BuTx and the muscle subsequently cultured for 24 hr. Loss of toxin again occurred more rapidly from extrajunctional receptors than from junctional receptors. The loss from extrajunctional receptors was described by a single first-order rate constant whose corresponding half-time was 8-11 hr. Loss was almost completely blocked by sodium cyanide and dinitrophenol and was inhibited by puromycin and cycloheximide. The radioactivity recovered in the medium was largely monoiodotyrosine. These results are consistent with...Continue Reading

Citations

Jun 1, 1988·Journal of Neuroimmunology·J P O'MalleyJ J Bray
Oct 1, 1994·Brain Research. Molecular Brain Research·S P Jayawickreme, T Claudio
Sep 1, 1996·Toxicon : Official Journal of the International Society on Toxinology·M IsmailA M Morad
Jan 1, 1987·Comparative Biochemistry and Physiology. B, Comparative Biochemistry·R SchaferS P Fracek
Oct 1, 1980·Archives internationales de physiologie et de biochimie·G L GraffP Goldschmidt
Aug 16, 2015·Journal of Muscle Research and Cell Motility·Siegfried StrackRüdiger Rudolf
Jan 1, 1981·Annals of the New York Academy of Sciences·P W BermanJ H Steinbach
Jan 1, 1981·Annals of the New York Academy of Sciences·D B DrachmanE F Stanley
May 24, 2008·Neuron·Thomas M Newpher, Michael D Ehlers
Jan 1, 1997·Molecular and Cellular Neurosciences·W D PhillipsP G Noakes
Aug 1, 1977·Developmental Biology·S A Cohen, G D Fischbach
Aug 14, 1999·Critical Care Medicine·L D MartinP P O'Rourke
Oct 1, 1991·Muscle & Nerve·D M Wetzel, M M Salpeter
Jan 1, 1987·Journal of Neuroscience Research·M I GlavinovićR Miledi
Apr 22, 1988·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·I ParkerR Miledi
Jan 1, 1987·Annals of the New York Academy of Sciences·E F Stanley, D B Drachman
Jan 1, 1987·Annals of the New York Academy of Sciences·Z W HallS M Schuetze
May 29, 2012·The Journal of Pharmacology and Experimental Therapeutics·Eric J TarchaShawn P Iadonato
Jul 14, 1997·The Journal of Cell Biology·J P O'MalleyM M Salpeter
Jan 19, 1978·The New England Journal of Medicine·D B Drachman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.